Abstract
Background: Foetal megacystis is the enlargement of the foetal bladder seen on prenatal ultrasound. Diagnosing the underlying cause of foetal megacystis in the antenatal period is often challenging due to the many possible underlying aetiologies, including various obstructive and non-obstructive causes. Summary: The detection of foetal megacystis leads to an extensive diagnostic conundrum. Counselling, prognostication, and prenatal management may prove challenging. Prenatal intervention has been trialled with limited success. Key Messages: This review article aims to be a practical guide to assist with the diagnosis, management and counselling for foetal megacystis in each trimester. It summarizes the evidence for each differential diagnosis and how to distinguish between them.
Journal Section:
Prenatal Diagnosis
Plain Language Summary
Megacystis, or an enlarged foetal bladder, is an uncommon but important finding on prenatal ultrasound. Once seen, it is important to determine the underlying aetiology to guide appropriate investigations, management and counselling of the families. This review article aims to demystify megacystis and offers a practical guide for the diagnosis and management of these cases.
Journal Section:
Prenatal Diagnosis
References
1.
Sebire
NJ
, Von Kaisenberg
C
, Rubio
C
, Snijders
RJ
, Nicolaides
KH
. Fetal megacystis at 10-14 weeks of gestation
. Ultrasound Obstet Gynecol
. 1996
;8
(6
):387
–90
. 2.
Taghavi
K
, Sharpe
C
, Stringer
MD
. Fetal megacystis: a systematic review
. J Pediatr Urol
. 2017
;13
(1
):7
–15
. 3.
Lesieur
E
, Barrois
M
, Bourdon
M
, Blanc
J
, Loeuillet
L
, Delteil
C
, et al. Megacystis in the first trimester of pregnancy: prognostic factors and perinatal outcomes
. PLoS One
. 2021
;16
(9
):e0255890
. 4.
Favre
R
, Kohler
M
, Gasser
B
, Muller
F
, Nisand
I
. Early fetal megacystis between 11 and 15 weeks of gestation
. Ultrasound Obstet Gynecol
. 1999
;14
(6
):402
–6
. 5.
Maizels
M
, Alpert
SA
, Houston
JT
, Sabbagha
RE
, Parilla
BV
, MacGregor
SN
. Fetal bladder sagittal length: a simple monitor to assess normal and enlarged fetal bladder size, and forecast clinical outcome
. J Urol
. 2004
;172
(5 Pt 1
):1995
–9
. 6.
Fontanella
F
, Maggio
L
, Verheij
J
, Duin
LK
, Adama Van Scheltema
PN
, Cohen-Overbeek
TE
, et al. Fetal megacystis: a lot more than LUTO
. Ultrasound Obstet Gynecol
. 2019
;53
(6
):779
–87
. 7.
Kao
C
, Lauzon
J
, Brundler
MA
, Tang
S
, Somerset
D
. Perinatal outcome and prognostic factors of fetal megacystis diagnosed at 11-14 week’s gestation
. Prenat Diagn
. 2021
;41
(3
):308
–15
. 8.
Miller
R
. Fetal lower urinary tract obstruction: an update
. Open Urol Nephrol J
. 2015
;8
(1
):124
–35
. 9.
10.
Liao
AW
, Sebire
NJ
, Geerts
L
, Cicero
S
, Nicolaides
KH
. Megacystis at 10-14 weeks of gestation: chromosomal defects and outcome according to bladder length
. Ultrasound Obstet Gynecol
. 2003
;21
(4
):338
–41
. 11.
Bornes
M
, Spaggiari
E
, Schmitz
T
, Dreux
S
, Czerkiewicz
I
, Delezoide
AL
, et al. Outcome and etiologies of fetal megacystis according to the gestational age at diagnosis
. Prenat Diagn
. 2013
;33
(12
):1162
–6
. 12.
Arena
S
, Iacona
R
, Impellizzeri
P
, Russo
T
, Marseglia
L
, Gitto
E
, et al. Physiopathology of vesico-ureteral reflux
. Ital J Pediatr
. 2016
;42
(1
):103
. 13.
Fontanella
F
, Duin
LK
, Adama van Scheltema
PN
, Cohen-Overbeek
TE
, Pajkrt
E
, Bekker
M
, et al. Prenatal diagnosis of LUTO: improving diagnostic accuracy
. Ultrasound Obstet Gynecol
. 2018
;52
(6
):739
–43
. 14.
Buinoiu
N
, Panaitescu
A
, Demetrian
M
, Ionescu
S
, Peltecu
G
, Veduta
A
. Ultrasound prenatal diagnosis of typical megacystis, microcolon, intestinal hypoperistalsis syndrome
. Clin Case Rep
. 2018
;6
(5
):855
–8
. 15.
Ambartsumyan
L
. Megacystis-microcolon-intestinal hypoperistalsis syndrome overview
. In: GeneReviews
. Seattle (WA)
: Univerity of Washignton
; 2019
. Available from: https://www.ncbi.nlm.nih.gov/books/NBK540960/16.
Lopes
RI
, Baker
LA
, Dénes
FT
. Modern management of and update on prune belly syndrome
. J Pediatr Urol
. 2021
;17
(4
):548
–54
. 17.
Arlen
AM
, Nawaf
C
, Kirsch
AJ
. Prune belly syndrome: current perspectives
. Pediatr Health Med Ther
. 2019
;10
:75
–81
. 18.
Haeri
S
. Fetal lower urinary tract obstruction (LUTO): a practical review for providers
. Matern Health Neonatol Perinatol
. 2015
;1
:26
. 19.
Ruano
R
, Sananes
N
, Sangi-Haghpeykar
H
, Hernandez-Ruano
S
, Moog
R
, Becmeur
F
, et al. Fetal intervention for severe lower urinary tract obstruction: a multicenter case-control study comparing fetal cystoscopy with vesicoamniotic shunting
. Ultrasound Obstet Gynecol
. 2015
;45
(4
):452
–8
. 20.
Ruano
R
, Sananes
N
, Wilson
C
, Au
J
, Koh
CJ
, Gargollo
P
, et al. Fetal lower urinary tract obstruction: proposal for standardized multidisciplinary prenatal management based on disease severity
. Ultrasound Obstet Gynecol
. 2016
;48
(4
):476
–82
. 21.
Capone
V
, Persico
N
, Berrettini
A
, Decramer
S
, De Marco
EA
, De Palma
D
, et al. Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group
. Nat Rev Urol
. 2022
;19
(5
):295
–303
. 22.
Al-Salem
A
. Posterior urethral valve
. In: An illustrated guide to pediatric surgery
. Cham
: Springer
; 2014
.23.
Herbst
KW
, Tomlinson
P
, Lockwood
G
, Mosha
MH
, Wang
Z
, D'Alessandri-Silva
C
. Survival and kidney outcomes of children with an early diagnosis of posterior urethral valves
. Clin J Am Soc Nephrol
. 2019
;14
(11
):1572
–80
. 24.
Fontanella
F
, Groen
H
, Duin
LK
, Suresh
S
, Bilardo
CM
. Z-scores of fetal bladder size for antenatal differential diagnosis between posterior urethral valves and urethral atresia
. Ultrasound Obstet Gynecol
. 2021
;58
(6
):875
–81
. 25.
Society for Maternal-Fetal Medicine
; Ghaffari
N
. Ectopic ureterocele
. Am J Obstet Gynecol
. 2021
;225
(5
):B14
–5
. 26.
Chitrit
Y
, Bourdon
M
, Korb
D
, Grapin-Dagorno
C
, Joinau-Zoulovits
F
, Vuillard
E
, et al. Posterior urethral valves and vesicoureteral reflux: can prenatal ultrasonography distinguish between these two conditions in male fetuses
. Prenat Diagn
. 2016
;36
(9
):831
–7
. 27.
Kamil
ES
. Recent advances in the understanding and management of primary vesicoureteral reflux and reflux nephropathy
. Curr Opin Nephrol Hypertens
. 2000
;9
(2
):139
–42
. 28.
Thomas
DFM
. The embryology of persistent cloaca and urogenital sinus malformations
. Asian J Androl
. 2020
;22
(2
):124
–8
. 29.
Gupta
A
, Bischoff
A
, Peña
A
, Runck
LA
, Guasch
G
. The great divide: septation and malformation of the cloaca, and its implications for surgeons
. Pediatr Surg Int
. 2014
;30
(11
):1089
–95
. 30.
Shah
K
, Nayak
SS
, Shukla
A
, Girisha
KM
. Spectrum of urorectal septum malformation sequence
. Congenit Anom
. 2016
;56
(3
):119
–26
. 31.
Peiro
JL
, Scorletti
F
, Sbragia
L
. Prenatal diagnosis of cloacal malformation
. Semin Pediatr Surg
. 2016
;25
(2
):71
–5
. 32.
Winkler
N
, Kennedy
A
, Woodward
P
. Cloacal malformation: the “ins and outs” of prenatal diagnosis. Radiological society of north America 2010 scientific assembly and annual Meeting2010
.33.
Huang
G
, Zheng
CJ
, Chu
GY
, Liu
SY
. Cloacal malformation: a rare case report and review of prenatal imagings
. Medicine
. 2020
;99
(42
):e21839
. 34.
Lubusky
M
, Prochazka
M
, Dhaifalah
I
, Horak
D
, Geierova
M
, Santavy
J
. Fetal enterolithiasis: prenatal sonographic and MRI diagnosis in two cases of urorectal septum malformation (URSM) sequence
. Prenat Diagn
. 2006
;26
(4
):345
–9
. 35.
Uchida
K
, Koike
Y
, Matsushita
K
, Nagano
Y
, Hashimoto
K
, Otake
K
, et al. Meconium peritonitis: prenatal diagnosis of a rare entity and postnatal management
. Intractable Rare Dis Res
. 2015
;4
(2
):93
–7
. 36.
Han
JH
, Lee
YS
, Im
YJ
, Kim
SW
, Lee
MJ
, Han
SW
. Clinical implications of obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome in the prepubertal age group
. PLoS One
. 2016
;11
(11
):e0166776
. 37.
Farrugia
MK
, Kilby
MD
. Therapeutic intervention for fetal lower urinary tract obstruction: current evidence and future strategies
. J Pediatr Urol
. 2021
;17
(2
):193
–9
. 38.
Ruano
R
, Dunn
T
, Braun
MC
, Angelo
JR
, Safdar
A
. Lower urinary tract obstruction: fetal intervention based on prenatal staging
. Pediatr Nephrol
. 2017
;32
(10
):1871
–8
. 39.
Kohaut
J
, Holtkamp
G
, Fischer-Mertens
J
, Schulten
D
, Kohl
S
, Habbig
S
, et al. A new spectrum of neonatal urethral pathologies in the era of early vesicoamniotic shunting
. World J Urol
. 2024
;42
(1
):589
. 40.
Fontanella
F
, van Scheltema
PNA
, Duin
L
, Cohen-Overbeek
TE
, Pajkrt
E
, Bekker
MN
, et al. Antenatal staging of congenital lower urinary tract obstruction
. Ultrasound Obstet Gynecol
. 2019
;53
(4
):520
–4
. 41.
Morris
RK
, Quinlan-Jones
E
, Kilby
MD
, Khan
KS
. Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in cases of congenital urinary tract obstruction
. Prenat Diagn
. 2007
;27
(10
):900
–11
. 42.
Morris
RK
, Ruano
R
, Kilby
MD
. Effectiveness of fetal cystoscopy as a diagnostic and therapeutic intervention for lower urinary tract obstruction: a systematic review
. Ultrasound Obstet Gynecol
. 2011
;37
(6
):629
–37
. 43.
Nicolini
U
, Fisk
NM
, Rodeck
CH
, Beacham
J
. Fetal urine biochemistry: an index of renal maturation and dysfunction
. Br J Obstet Gynaecol
. 1992
;99
(1
):46
–50
. 44.
Shannon
KJ
, VanLoh
S
, Espinoza
J
, Sanz-Cortes
M
, Donepudi
R
, Shamshirsaz
AA
, et al. Fetal bladder morphology as a predictor of outcome in fetal lower urinary tract obstruction
. Prenat Diagn
. 2024
;44
(2
):124
–30
. 45.
Ruano
R
, Safdar
A
, Au
J
, Koh
CJ
, Gargollo
P
, Shamshirsaz
AA
, et al. Defining and predicting 'intrauterine fetal renal failure’ in congenital lower urinary tract obstruction
. Pediatr Nephrol
. 2016
;31
(4
):605
–12
. 46.
Morris
RK
, Malin
GL
, Quinlan-Jones
E
, Middleton
LJ
, Hemming
K
, Burke
D
, et al. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial
. Lancet
. 2013
;382
(9903
):1496
–506
. 47.
Nassr
AA
, Shazly
SAM
, Abdelmagied
AM
, Araujo Júnior
E
, Tonni
G
, Kilby
MD
, et al. Effectiveness of vesicoamniotic shunt in fetuses with congenital lower urinary tract obstruction: an updated systematic review and meta-analysis
. Ultrasound Obstet Gynecol
. 2017
;49
(6
):696
–703
. 48.
Harrison
MR
, Golbus
MS
, Filly
RA
, Callen
PW
, Katz
M
, de Lorimier
AA
, et al. Fetal surgery for congenital hydronephrosis
. N Engl J Med
. 1982
;306
(10
):591
–3
. 49.
Strizek
B
, Spicher
T
, Gottschalk
I
, Böckenhoff
P
, Simonini
C
, Berg
C
, et al. Vesicoamniotic shunting before 17 + 0 weeks in fetuses with lower urinary tract obstruction (LUTO): comparison of Somatex vs. Harrison shunt systems
. J Clin Med
. 2022
;11
(9
):2359
. 50.
Chen
L
, Guan
J
, Gu
H
, Zhang
M
. Outcomes in fetuses diagnosed with megacystis: systematic review and meta-analysis
. Eur J Obstet Gynecol Reprod Biol
. 2019
;233
:120
–6
. 51.
Mammas
IN
, Spandidos
DA
. The perspectives and the challenges of paediatric radiology: an interview with Dr Georgia papaioannou, head of the paediatric radiology department at the “mitera” children’s hospital in athens, Greece
. Exp Ther Med
. 2019
;18
(4
):3238
–42
. 52.
Mileto
A
, Itani
M
, Katz
DS
, Siebert
JR
, Dighe
MK
, Dubinsky
TJ
, et al. Fetal urinary tract anomalies: review of pathophysiology, imaging, and management
. AJR Am J Roentgenol
. 2018
;210
(5
):1010
–21
. 53.
Riccabona
M
. Imaging of the neonatal genito-urinary tract
. Eur J Radiol
. 2006
;60
(2
):187
–98
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
